title: Renin-angiotensin system revisited.
abstract: New components and functions of the renin-angiotensin system (RAS) are still being unravelled. The classical RAS as it looked in the middle 1970s consisted of circulating renin, acting on angiotensinogen to produce angiotensin I, which in turn was converted into angiotensin II (Ang II) by angiotensin-converting enzyme (ACE). Ang II, still considered the main effector of RAS was believed to act only as a circulating hormone via angiotensin receptors, AT1 and AT2. Since then, an expanded view of RAS has gradually emerged. Local tissue RAS systems have been identified in most organs. Recently, evidence for an intracellular RAS has been reported. The new expanded view of RAS therefore covers both endocrine, paracrine and intracrine functions. Other peptides of RAS have been shown to have biological actions; angiotensin 2-8 heptapeptide (Ang III) has actions similar to those of Ang II. Further, the angiotensin 3-8 hexapeptide (Ang IV) exerts its actions via insulin-regulated amino peptidase receptors. Finally, angiotensin 1-7 (Ang 1-7) acts via mas receptors. The discovery of another ACE2 was an important complement to this picture. The recent discovery of renin receptors has made our view of RAS unexpectedly complex and multilayered. The importance of RAS in cardiovascular disease has been demonstrated by the clinical benefits of ACE inhibitors and AT1 receptor blockers. Great expectations are now generated by the introduction of renin inhibitors. Indeed, RAS regulates much more and diverse physiological functions than previously believed.
authors.affiliation: Minerva Institute for Medical Research and Department of Internal Medicine, Helsinki University Central Hospital, Helsinki, Finland. frej.fyhrquist@helsinki.fi
authors.forename: F
authors.initials: F
authors.lastname: Fyhrquist
authors.forename: O
authors.initials: O
authors.lastname: Saijonmaa
mesh_terms: D000803:Angiotensin I / Q000502:physiology; D000804:Angiotensin II / Q000031:analogs & derivatives / Q000502:physiology; D000805:Angiotensin III / Q000502:physiology; D000085962:Angiotensin-Converting Enzyme 2; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D010446:Peptide Fragments / Q000502:physiology; D007703:Peptidyl-Dipeptidase A / Q000502:physiology; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D012084:Renin-Angiotensin System / Q000235:genetics / Q000502:physiology*; D025262:Vacuolar Proton-Translocating ATPases / Q000502:physiology; D000093342:Prorenin Receptor
chemical_list: D000803:Angiotensin I; D000804:Angiotensin II; D000805:Angiotensin III; D000085962:Angiotensin-Converting Enzyme 2; D000806:Angiotensin-Converting Enzyme Inhibitors; D010446:Peptide Fragments; D007703:Peptidyl-Dipeptidase A; D044140:Receptor, Angiotensin, Type 1; D011956:Receptors, Cell Surface; D025262:Vacuolar Proton-Translocating ATPases; C458319:ATP6AP2 protein, human; D000093342:Prorenin Receptor; C012877:angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-; C000705307:ACE2 protein, human; C118790:angiotensin I (1-7)
references.citation: Trends Cardiovasc Med. 2007 Jan;17(1):19-25
references.pmid: 17210474
references.citation: Curr Opin Nephrol Hypertens. 2006 Mar;15(2):159-66
references.pmid: 16481883
references.citation: J Hypertens. 2007 May;25(5):951-8
references.pmid: 17414657
references.citation: Hypertension. 2005 Sep;46(3):454-62
references.pmid: 16103272
references.citation: J Cardiovasc Pharmacol. 2007 Jul;50(1):3-8
references.pmid: 17666909
references.citation: Nature. 1995 Oct 26;377(6551):748-50
references.pmid: 7477267
references.citation: J Hypertens. 2005 Apr;23(4):673-81
references.pmid: 15775766
references.citation: Eur Heart J. 2005 Feb;26(4):369-75; discussion 322-4
references.pmid: 15671045
references.citation: J Clin Invest. 2002 Jun;109(11):1417-27
references.pmid: 12045255
references.citation: Circulation. 2007 Feb 13;115(6):725-32
references.pmid: 17261659
references.citation: Curr Opin Nephrol Hypertens. 2007 Mar;16(2):129-33
references.pmid: 17293688
references.citation: Pharmacogenomics J. 2004;4(1):17-23
references.pmid: 14735111
references.citation: Hypertension. 2006 Mar;47(3):515-21
references.pmid: 16365192
references.citation: J Hypertens Suppl. 2006 Mar;24(1):S115-21
references.pmid: 16601564
references.citation: Proc Natl Acad Sci U S A. 1988 Jun;85(11):4095-8
references.pmid: 3375255
references.citation: Pharmacol Rev. 1993 Jun;45(2):205-51
references.pmid: 8372104
references.citation: Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E227-32
references.pmid: 15082419
references.citation: Kidney Int. 1999 Dec;56(6):2173-80
references.pmid: 10594793
references.citation: FASEB J. 2005 Apr;19(6):617-9
references.pmid: 15665034
references.citation: Metabolism. 2006 Apr;55(4):478-88
references.pmid: 16546478
references.citation: Hum Mol Genet. 2005 Apr 15;14(8):1019-27
references.pmid: 15746149
references.citation: Curr Opin Nephrol Hypertens. 2006 Jan;15(1):8-13
references.pmid: 16340660
references.citation: Circ Res. 2006 Mar 3;98(4):463-71
references.pmid: 16514079
references.citation: Nat Med. 2005 Feb;11(2):160-6
references.pmid: 15665832
references.citation: Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97
references.pmid: 16870827
references.citation: J Hypertens. 2007 Jan;25(1):25-35
references.pmid: 17143168
references.citation: Diabetologia. 2006 Feb;49(2):321-31
references.pmid: 16416272
references.citation: Curr Opin Pharmacol. 2007 Apr;7(2):140-5
references.pmid: 17303473
references.citation: Hypertension. 2005 Feb;45(2):163-9
references.pmid: 15630047
references.citation: Lancet. 2000 May 6;355(9215):1582-7
references.pmid: 10821361
references.citation: J Clin Invest. 1990 Oct;86(4):1352-7
references.pmid: 2212017
references.citation: J Hypertens. 2005 Jul;23(7):1311-25
references.pmid: 15942450
references.citation: Nature. 1990 Apr 5;344(6266):541-4
references.pmid: 2181319
references.citation: Circulation. 2003 May 27;107(20):2522-4
references.pmid: 12777313
references.citation: Regul Pept. 2006 Jan 15;133(1-3):10-2
references.pmid: 16325280
references.citation: Hypertension. 2007 Mar;49(3):625-30
references.pmid: 17190872
references.citation: Lancet. 2002 Mar 23;359(9311):995-1003
references.pmid: 11937178
references.citation: J Hypertens. 2006 Feb;24(2):243-56
references.pmid: 16508564
references.citation: J Biol Chem. 1995 Oct 6;270(40):23612-8
references.pmid: 7559527
references.citation: Pharmacol Ther. 2006 Dec;112(3):668-76
references.pmid: 16837049
references.citation: Hypertension. 2004 May;43(5):970-6
references.pmid: 15007027
references.citation: Nature. 2002 Jun 20;417(6891):822-8
references.pmid: 12075344
references.citation: Hypertension. 2006 Mar;47(3):537-44
references.pmid: 16380540
references.citation: Hypertension. 2003 Oct;42(4):500-6
references.pmid: 12925562
references.citation: Trends Endocrinol Metab. 2007 Jul;18(5):208-14
references.pmid: 17509892
references.citation: J Hypertens. 2004 Dec;22(12):2253-61
references.pmid: 15614015
references.citation: J Clin Invest. 2004 Oct;114(8):1128-35
references.pmid: 15489960
references.citation: Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8
references.pmid: 16481882
references.citation: J Biol Chem. 1982 Apr 10;257(7):3759-65
references.pmid: 6120943
references.citation: J Hypertens. 1995 Dec;13(12 Pt 2):1602-9
references.pmid: 8903618
references.citation: Circ Res. 2000 Sep 1;87(5):E1-9
references.pmid: 10969042
references.citation: Cardiovasc Res. 2007 Feb 1;73(3):463-9
references.pmid: 17049503
references.citation: Prog Biophys Mol Biol. 2006 May-Jun;91(1-2):163-98
references.pmid: 16009403
references.citation: Nature. 2005 Jul 7;436(7047):112-6
references.pmid: 16001071
references.citation: J Hypertens Suppl. 2006 Mar;24(1):S101-6
references.pmid: 16601562
references.citation: Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1351-8
references.pmid: 17557916
references.citation: Diabetes. 2006 Feb;55(2):367-74
references.pmid: 16443769
references.citation: Circ Res. 2005 Jun 10;96(11):1135-44
references.pmid: 15947253
references.citation: Science. 1977 Apr 22;196(4288):441-4
references.pmid: 191908
references.citation: Lancet. 2005 Dec 10;366(9502):2026-33
references.pmid: 16338452
references.citation: Nature. 1995 Oct 26;377(6551):744-7
references.pmid: 7477266
references.citation: Drugs. 2006;66(9):1169-77
references.pmid: 16827595
references.citation: Mol Aspects Med. 2004 Feb-Apr;25(1-2):27-36
references.pmid: 15051314
references.citation: Curr Opin Nephrol Hypertens. 2007 Mar;16(2):122-8
references.pmid: 17293687
references.citation: Science. 2002 Jun 28;296(5577):2401-3
references.pmid: 12089445
references.citation: Cell Tissue Res. 2006 Nov;326(2):599-616
references.pmid: 16555051
references.citation: Lancet. 2002 Sep 7;360(9335):752-60
references.pmid: 12241832
references.citation: Curr Opin Nephrol Hypertens. 2007 Mar;16(2):116-21
references.pmid: 17293686
references.citation: J Physiol. 2007 Apr 1;580(Pt 1):31-7
references.pmid: 17218353
references.citation: Curr Opin Nephrol Hypertens. 2005 Jan;14(1):67-71
references.pmid: 15586018
references.citation: Kidney Int. 2005 Nov;68(5):2189-96
references.pmid: 16221218
references.citation: Circulation. 2005 May 24;111(20):2605-10
references.pmid: 15897343
references.citation: J Am Soc Nephrol. 2006 Jul;17(7):1950-61
references.pmid: 16738017
references.citation: N Engl J Med. 2008 Apr 10;358(15):1547-59
references.pmid: 18378520
references.citation: Cell. 1992 Oct 2;71(1):169-80
references.pmid: 1394429
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11968-73
references.pmid: 8876246
references.citation: Acta Physiol (Oxf). 2006 Oct;188(2):129-38
references.pmid: 16948800
references.citation: Nat Med. 2005 Aug;11(8):875-9
references.pmid: 16007097
references.citation: Regul Pept. 2004 Aug 15;120(1-3):5-13
references.pmid: 15177915
references.citation: J Renin Angiotensin Aldosterone Syst. 2001 Jun;2(2):96-102
references.pmid: 11881106
references.citation: J Biol Chem. 2000 Oct 27;275(43):33238-43
references.pmid: 10924499
references.citation: J Biol Chem. 2001 Dec 28;276(52):48623-6
references.pmid: 11707427
references.citation: J Hypertens. 2001 Oct;19(10):1783-7
references.pmid: 11593098
references.citation: Brain Res. 1999 Mar 6;821(1):150-9
references.pmid: 10064799
references.citation: Trends Pharmacol Sci. 2004 Oct;25(10):518-22
references.pmid: 15380935
references.citation: Int J Biochem Cell Biol. 2003 Jun;35(6):807-25
references.pmid: 12676168
references.citation: Hypertension. 2003 Feb;41(2):313-21
references.pmid: 12574101
references.citation: J Clin Invest. 1995 Nov;96(5):2515-20
references.pmid: 7593643
references.citation: J Clin Invest. 2006 Aug;116(8):2218-25
references.pmid: 16878172
references.citation: Physiol Rev. 2006 Jul;86(3):747-803
references.pmid: 16816138
references.citation: Cell Mol Life Sci. 2004 Nov;61(21):2728-37
references.pmid: 15549174
references.citation: Circ Res. 1996 Oct;79(4):765-72
references.pmid: 8831500
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R274-82
references.pmid: 17197644
references.citation: Lancet. 2006 Oct 21;368(9545):1449-56
references.pmid: 17055947
references.citation: Regul Pept. 2006 Jan 15;133(1-3):1-9
references.pmid: 16226324
references.citation: Hypertension. 2006 May;47(5):996-1002
references.pmid: 16567589
references.citation: J Mol Med (Berl). 2006 Oct;84(10):814-20
references.pmid: 16988814